BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 24810245)

  • 1. Tumor acquisition for biomarker research in lung cancer.
    Stevenson M; Christensen J; Shoemaker D; Foster T; Barry WT; Tong BC; Wahidi M; Shofer S; Datto M; Ginsburg G; Crawford J; D'Amico T; Ready N
    Cancer Invest; 2014 Jul; 32(6):291-8. PubMed ID: 24810245
    [TBL] [Abstract][Full Text] [Related]  

  • 2. EBUS-TBNA provides highest RNA yield for multiple biomarker testing from routinely obtained small biopsies in non-small cell lung cancer patients - a comparative study of three different minimal invasive sampling methods.
    Schmid-Bindert G; Wang Y; Jiang H; Sun H; Henzler T; Wang H; Pilz LR; Ren S; Zhou C
    PLoS One; 2013; 8(10):e77948. PubMed ID: 24205040
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aspects of lung cancer gene expression profiling.
    Müller-Hagen G; Beinert T; Sommer A
    Curr Opin Drug Discov Devel; 2004 May; 7(3):290-303. PubMed ID: 15216932
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gene expression profiling of non-small cell lung cancer.
    Singhal S; Miller D; Ramalingam S; Sun SY
    Lung Cancer; 2008 Jun; 60(3):313-24. PubMed ID: 18440087
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Feasibility of image-guided transthoracic core-needle biopsy in the BATTLE lung trial.
    Tam AL; Kim ES; Lee JJ; Ensor JE; Hicks ME; Tang X; Blumenschein GR; Alden CM; Erasmus JJ; Tsao A; Lippman SM; Hong WK; Wistuba II; Gupta S
    J Thorac Oncol; 2013 Apr; 8(4):436-42. PubMed ID: 23442309
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Two-Gene Prognostic Classifier for Early-Stage Lung Squamous Cell Carcinoma in Multiple Large-Scale and Geographically Diverse Cohorts.
    Noro R; Ishigame T; Walsh N; Shiraishi K; Robles AI; Ryan BM; Schetter AJ; Bowman ED; Welsh JA; Seike M; Gemma A; Skaug V; Mollerup S; Haugen A; Yokota J; Kohno T; Harris CC
    J Thorac Oncol; 2017 Jan; 12(1):65-76. PubMed ID: 27613525
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methylation markers of early-stage non-small cell lung cancer.
    Lokk K; Vooder T; Kolde R; Välk K; Võsa U; Roosipuu R; Milani L; Fischer K; Koltsina M; Urgard E; Annilo T; Metspalu A; Tõnisson N
    PLoS One; 2012; 7(6):e39813. PubMed ID: 22768131
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lung Carcinoma Predictive Biomarker Testing by Immunoperoxidase Stains in Cytology and Small Biopsy Specimens: Advantages and Limitations.
    Zhou F; Moreira AL
    Arch Pathol Lab Med; 2016 Dec; 140(12):1331-1337. PubMed ID: 27588333
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bioinformatics analysis and experimental validation of TTK as a biomarker for prognosis in non-small cell lung cancer.
    Chen J; Wu R; Xuan Y; Jiang M; Zeng Y
    Biosci Rep; 2020 Oct; 40(10):. PubMed ID: 32969465
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Liquid biopsy assay for lung carcinoma using centrifuged supernatants from fine-needle aspiration specimens.
    Hannigan B; Ye W; Mehrotra M; Lam V; Bolivar A; Zalles S; Barkoh BA; Duose D; Hu PC; Broaddus R; Stewart J; Heymach J; Medeiros LJ; Wistuba I; Luthra R; Roy-Chowdhuri S
    Ann Oncol; 2019 Jun; 30(6):963-969. PubMed ID: 30887015
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reliability of Small Biopsy Samples Compared With Resected Specimens for the Determination of Programmed Death-Ligand 1 Expression in Non--Small-Cell Lung Cancer.
    Kitazono S; Fujiwara Y; Tsuta K; Utsumi H; Kanda S; Horinouchi H; Nokihara H; Yamamoto N; Sasada S; Watanabe S; Asamura H; Tamura T; Ohe Y
    Clin Lung Cancer; 2015 Sep; 16(5):385-90. PubMed ID: 25937270
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of the NEDD4L gene as a prognostic marker by integrated microarray analysis of copy number and gene expression profiling in non-small cell lung cancer.
    Sakashita H; Inoue H; Akamine S; Ishida T; Inase N; Shirao K; Mori M; Mimori K
    Ann Surg Oncol; 2013 Dec; 20 Suppl 3():S590-8. PubMed ID: 23812770
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circular RNA F-circEA produced from EML4-ALK fusion gene as a novel liquid biopsy biomarker for non-small cell lung cancer.
    Tan S; Gou Q; Pu W; Guo C; Yang Y; Wu K; Liu Y; Liu L; Wei YQ; Peng Y
    Cell Res; 2018 Jun; 28(6):693-695. PubMed ID: 29628502
    [No Abstract]   [Full Text] [Related]  

  • 14. Biomarker testing and time to treatment decision in patients with advanced nonsmall-cell lung cancer.
    Lim C; Tsao MS; Le LW; Shepherd FA; Feld R; Burkes RL; Liu G; Kamel-Reid S; Hwang D; Tanguay J; da Cunha Santos G; Leighl NB
    Ann Oncol; 2015 Jul; 26(7):1415-21. PubMed ID: 25922063
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High expression of serum miR-21 and tumor miR-200c associated with poor prognosis in patients with lung cancer.
    Liu XG; Zhu WY; Huang YY; Ma LN; Zhou SQ; Wang YK; Zeng F; Zhou JH; Zhang YK
    Med Oncol; 2012 Jun; 29(2):618-26. PubMed ID: 21516486
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gene profiling of clinical routine biopsies and prediction of survival in non-small cell lung cancer.
    Baty F; Facompré M; Kaiser S; Schumacher M; Pless M; Bubendorf L; Savic S; Marrer E; Budach W; Buess M; Kehren J; Tamm M; Brutsche MH
    Am J Respir Crit Care Med; 2010 Jan; 181(2):181-8. PubMed ID: 19833826
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular Testing in Lung Cancer: Recommendations and Update.
    Borczuk AC
    Surg Pathol Clin; 2024 Jun; 17(2):307-320. PubMed ID: 38692813
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multiple Biomarker Testing Tissue Consumption and Completion Rates With Single-gene Tests and Investigational Use of Oncomine Dx Target Test for Advanced Non-Small-cell Lung Cancer: A Single-center Analysis.
    Yu TM; Morrison C; Gold EJ; Tradonsky A; Layton AJ
    Clin Lung Cancer; 2019 Jan; 20(1):20-29.e8. PubMed ID: 30243889
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tissue banking of diagnostic lung cancer biopsies for extraction of high quality RNA.
    Lawson MH; Rassl DM; Cummings NM; Russell R; Morjaria JB; Brenton JD; Murphy G; Rintoul RC
    J Thorac Oncol; 2010 Jul; 5(7):956-63. PubMed ID: 20512072
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Feasibility of using low-volume tissue samples for gene expression profiling of advanced non-small cell lung cancers.
    Lim EH; Aggarwal A; Agasthian T; Wong PS; Tan C; Sim E; Tan L; Goh PS; Wang SC; Khoo KL; Mukherjee A; Khoo SM; Chua G; Nilsson B; Lee KH; Tan P
    Clin Cancer Res; 2003 Dec; 9(16 Pt 1):5980-7. PubMed ID: 14676123
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.